Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LOC102724788 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
EXOC7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TJAP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAMDC2-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
CEP89 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC4A11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TPSAB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DTNA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CIRBP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101928222 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANKRD13D - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RRNAD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FGFR3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCHCR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HMGXB3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DBF4B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on